# Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1] I.V. Infusion 400mg "CT" (トシリズマブＢＳ点滴静注４００ｍｇ「ＣＴ」)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399435A3024). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399435A3024
- **Product name (Japanese):** トシリズマブＢＳ点滴静注４００ｍｇ「ＣＴ」
- **Product name (English):** Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1] I.V. Infusion 400mg "CT"
- **Active ingredient:** トシリズマブ（遺伝子組換え）［トシリズマブ後続１］
- **Active ingredient (INN):** Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1]
- **Strength / unit:** ４００ｍｇ２０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** セルトリオン・ヘルスケア・ジャパン
- **Brand / generic:** Generic (後発医薬品)
- **NHI price (reference only):** JPY 33434 per ４００ｍｇ２０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399435A3024
- **JSON:** https://www.nifujipharma.com/api/drugs/6399435A3024

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Tocilizumab%20(Genetical%20Recombination)%20%5BTocilizumab%20Biosimilar%201%5D%20I.V.%20Infusion%20400mg%20%22CT%22%20(%E3%83%88%E3%82%B7%E3%83%AA%E3%82%BA%E3%83%9E%E3%83%96%EF%BC%A2%EF%BC%B3%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%94%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%80%8C%EF%BC%A3%EF%BC%B4%E3%80%8D)%20%2F%20YJ%206399435A3024#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1]

- [Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1] I.V. Infusion 80mg "CT" (トシリズマブＢＳ点滴静注８０ｍｇ「ＣＴ」)](https://www.nifujipharma.com/drugs/6399435A1021) — ８０ｍｇ４ｍＬ１瓶, セルトリオン・ヘルスケア・ジャパン, generic
- [Tocilizumab (Genetical Recombination) [Tocilizumab Biosimilar 1] I.V. Infusion 200mg "CT" (トシリズマブＢＳ点滴静注２００ｍｇ「ＣＴ」)](https://www.nifujipharma.com/drugs/6399435A2028) — ２００ｍｇ１０ｍＬ１瓶, セルトリオン・ヘルスケア・ジャパン, generic